X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare RASOYA PROTEINS with GSK Consumer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RASOYA PROTEINS vs GSK CONSUMER - Comparison Results

GSK CONSUMER 
   Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RASOYA PROTEINS GSK CONSUMER RASOYA PROTEINS/
GSK CONSUMER
 
P/E (TTM) x 2.6 37.4 6.9% View Chart
P/BV x 0.6 8.4 6.9% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 RASOYA PROTEINS   GSK CONSUMER
EQUITY SHARE DATA
    RASOYA PROTEINS
Mar-16
GSK CONSUMER
Mar-17
RASOYA PROTEINS/
GSK CONSUMER
5-Yr Chart
Click to enlarge
High Rs16,551 0.0%   
Low RsNA4,921 0.0%   
Sales per share (Unadj.) Rs0.4947.8 0.0%  
Earnings per share (Unadj.) Rs-2.3156.1 -1.5%  
Cash flow per share (Unadj.) Rs-2.2171.4 -1.3%  
Dividends per share (Unadj.) Rs070.00 0.0%  
Dividend yield (eoy) %01.2 0.0%  
Book value per share (Unadj.) Rs0.3742.4 0.0%  
Shares outstanding (eoy) m1,708.9342.06 4,063.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.06.1 16.6%   
Avg P/E ratio x-0.236.7 -0.5%  
P/CF ratio (eoy) x-0.233.5 -0.6%  
Price / Book Value ratio x1.67.7 21.2%  
Dividend payout %044.8 0.0%   
Avg Mkt Cap Rs m769241,265 0.3%   
No. of employees `0000.13.8 3.8%   
Total wages/salary Rs m594,580 1.3%   
Avg. sales/employee Rs Th5,246.610,471.4 50.1%   
Avg. wages/employee Rs Th400.71,203.1 33.3%   
Avg. net profit/employee Rs Th-26,690.41,724.9 -1,547.3%   
INCOME DATA
Net Sales Rs m76639,865 1.9%  
Other income Rs m72,439 0.3%   
Total revenues Rs m77342,303 1.8%   
Gross profit Rs m-2,9178,335 -35.0%  
Depreciation Rs m121642 18.9%   
Interest Rs m4528 160.8%   
Profit before tax Rs m-3,07510,104 -30.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-9280-   
Tax Rs m-1073,537 -3.0%   
Profit after tax Rs m-3,8976,567 -59.3%  
Gross profit margin %-380.720.9 -1,821.0%  
Effective tax rate %3.535.0 9.9%   
Net profit margin %-508.716.5 -3,088.3%  
BALANCE SHEET DATA
Current assets Rs m11141,446 0.3%   
Current liabilities Rs m2,89216,011 18.1%   
Net working cap to sales %-363.163.8 -569.1%  
Current ratio x02.6 1.5%  
Inventory Days Days2142 49.1%  
Debtors Days Days1529 50.6%  
Net fixed assets Rs m1,8645,362 34.8%   
Share capital Rs m1,709421 406.3%   
"Free" reserves Rs m-1,24930,806 -4.1%   
Net worth Rs m47031,227 1.5%   
Long term debt Rs m9600-   
Total assets Rs m6,24949,602 12.6%  
Interest coverage x-67.8364.5 -18.6%   
Debt to equity ratio x2.00-  
Sales to assets ratio x0.10.8 15.3%   
Return on assets %-61.613.3 -463.7%  
Return on equity %-829.521.0 -3,944.3%  
Return on capital %-276.932.4 -853.5%  
Exports to sales %5.40-   
Imports to sales %00-   
Exports (fob) Rs m41NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m412,591 1.6%   
Fx outflow Rs m0282 0.0%   
Net fx Rs m412,310 1.8%   
CASH FLOW
From Operations Rs m406,225 0.6%  
From Investments Rs mNA-6,218 0.0%  
From Financial Activity Rs m-42-3,615 1.2%  
Net Cashflow Rs m-3-3,608 0.1%  

Share Holding

Indian Promoters % 31.7 0.0 -  
Foreign collaborators % 0.0 72.5 -  
Indian inst/Mut Fund % 0.0 0.8 -  
FIIs % 3.7 12.0 30.8%  
ADR/GDR % 26.7 0.0 -  
Free float % 37.9 14.8 256.1%  
Shareholders   4,554 26,457 17.2%  
Pledged promoter(s) holding % 41.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RASOYA PROTEINS With:   DABUR  KAVERI SEED  JUBILANT FOODWORKS  GOODRICKE  ITC LTD  

Compare RASOYA PROTEINS With:   TIGER BRANDS (S. Africa)  NESTLE (Switz.)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Ends Volatile Day Flat; Realty Stocks Top Losers(Closing)

After opening the day in green and scaling new all-time high levels, share markets in India witnessed volatile trading activity throughout the day and ended the day flat.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

GSK Consumer: Slowdown in demand impacts sales (Quarterly Results Update - Detailed)

Oct 5, 2016

GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.

More Views on News

Most Popular

Has A Bank Ever Told You Its Deposits are Riskier than Stocks? These Should Have...(The 5 Minute Wrapup)

Jul 3, 2018

Left on their own, the banks would possibly have to mark down the value of deposits by 90% to 100%.

The Real Truth About India's FDI, Beyond WhatsApp(Vivek Kaul's Diary)

Jul 4, 2018

The FDI numbers do not look very impressive once we adjust for repatriations as well as the overall growth in the economy.

The 5-Point Checklist to Save You from Toxic Stocks(Profit Hunter)

Jul 2, 2018

Worried about investing in one of the poisonous stocks that keep emerging from the woodwork? This checklist could come to your rescue

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RASOYA PROTEINS SHARE PRICE


Jul 2, 2018 (Close)

TRACK RASOYA PROTEINS

  • Track your investment in RASOYA PROTEINS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON RASOYA PROTEINS

RASOYA PROTEINS 8-QTR ANALYSIS

COMPARE RASOYA PROTEINS WITH

MARKET STATS